OnCore Login

Return to Trial Database

GYN06-106

A Phase 2, Open-Label, Safety and Efficacy Study of Panzem® Nanocrystal Colloidal Dispersion Administered Orally in Patients With Recurrent or Resistant Epithelial Ovarian Cancer

Status

Study Completed

Cancer Type(s)

Ovarian

Study Contact

Publications

  • D Matei, J Schilder, N Menning, K Koneru, G Sutton
Activity of 2 Methoxyestradiol (Panzem® NCD) in Advanced, Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinomatosis
  • D Matei, J Schilder, G Sutton, S Perkins, T Breen, C Quon, C Sidor

Trial Locations

All sites in which the trial GYN06-106 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278